David Butler-Jones, the agency's head. In a June 2009 conference call with Gates officials, Butler-Jones acknowledged financial sustainability concerns, but he also noted benefits including technology, infrastructure, and human resource support for HIV vaccine development.

Two weeks after that call, the Gates Foundation presented a study suggesting adequate vaccine production capacity existed in the private sector. Critics said it ignored qualitative factors and the difficulty of academic research programs accessing trial facilities.

"Given this evidence ... it was agreed the government of Canada take the position of not moving forward with the facility project," a July 30 briefing note for Butler-Jones said. The goal was to develop a communications plan to that end by August. Nonetheless, none of the applicants knew of the decision until late January 2010, when theThe breast radiation injury litigation and the clinical oncologist.
A number of women with breast cancer believed they were suffering injury because radiotherapy had been given negligently. In March 1995, their solicitors were permitted by the High Court, to select 10 cases in order to further a group action. In the legal exchanges which followed, the principal issues put forward by the plaintiffs went through a number of modifications until finally, in December 1997, they were abandoned. Two cases came to trial and after a hearing of 21 days, the Judge found no negligence. Clinical oncologists should be aware of the course of the litigation and consider the lessons to be learned.